Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
James P. Scriven, CEO of IDB Invest, explores Latin American finance and investment strategies with the International Finance Corporation.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
James P. Scriven, CEO of IDB Invest
Recent Videos
00:10:00
Star Diamond Corp Eyes Production: Largest Undeveloped Diamond Project Nears Key Milestones|Ewan Mason,CEO,Star Diamond Corp
00:10:00
Phantom Resources: Advancing High-Potential Gold Discoveries in Nevada with Expert Leadership|Paul Cowley,CEO,Phenom Resources
00:10:00
West Red Lake Gold Mines Gears Up for Gold Production at Madsen Mine|Gwen Preston,Vice President, Communications,West Red Lake Gold Mines Ltd
00:10:00
StrikePoint Gold Gears Up for Drilling at Hercules Project in Nevada|Michael G. Allen,CEO,StrikePoint Gold Inc
00:10:00
Randy Smallwood’s Contributions to Precious Metals and Industry Leadership | Randy Smallwood, CEO , Wheaton Precious Metal.
00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
Suggestions
00:00:00
Advanced Oncotherapy present research potentially offering 'powerful weapon to resistant cancers' - Jonathan Farr, Chief Clinical Officer, Advanced Oncotherapy
00:00:00
Destiny Pharma's nasal spray project already delivering - Neil Clark, CEO, Destiny Pharma
00:10:00
CEO Kai Telanne Discusses Development and Investor Concerns | Kai Telanne, CEO, Alma Media Oyj.
00:10:00
Janice Zinck Discusses Her Role and Interests at the IMPC 2024
00:10:00
Banco Santander CEO Hector Grisi Highlights Strong Q1 Performance and Strategic Initiatives for 2024 | Hector Grisi , CEO , Banco Santander.
00:10:00
The Politics of Tribal Nonsense: Exploring Wokeness and Marxist Ideologies|Wilfred Reilly,Professor,Kentucky State University
00:10:00
Datamicron builds long term relationships with customers and partners through our dedicated and professional workforce|Jimmy Ting,MD,DataMicron Systems Sdn Bhd
00:10:00
Australia's Mineral Resources Identified | James Johnson, Chief Executive Officer at Geoscience Australia
00:10:00
AMMO, Inc Donates One Million Rounds to Ukrainian Armed Forces: A Message from CEO Fred Wagenhals | Fred Wagenhals, CEO, Ammo Inc.
00:10:00
Driving Growth and Innovation: Insights from ROCA Industry CEO IonuČ› Bindea | IonuČ› Bindea, CEO, ROCA Industry Holdingrock1 SA.
00:10:00
The CEO of Xerox discusses the services the company offers and its plans for expansion. | Steve Bandrowczak, CEO, Xerox Holdings CorpXRX:NYS
00:10:00
Development of a new generation of immune response modifier|Simon Wilkinson,CEO,Innate Immunotherapeutics Ltd